<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Although <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel disease</z:e> is associated with higher risk of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, the precise pathogenic mechanisms underlying this association are not completely understood </plain></SENT>
<SENT sid="1" pm="."><plain>Prohibitin 1 (<z:chebi fb="0" ids="53388">PHB</z:chebi>), a protein implicated in the regulation of proliferation, <z:mpath ids='MPATH_3'>apoptosis</z:mpath>, and transcription, is decreased in <z:mp ids='MP_0001858'>intestinal inflammation</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>In this study, we have established a key function for <z:chebi fb="0" ids="53388">PHB</z:chebi> in mediating <z:hpo ids='HP_0002583'>colitis</z:hpo>-associated <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain><z:mp ids='MP_0002169'>Wild-type</z:mp> and transgenic (Tg) mice specifically overexpressing <z:chebi fb="0" ids="53388">PHB</z:chebi> in intestinal epithelial cells were subjected to a classical two-stage protocol of <z:hpo ids='HP_0002583'>colitis</z:hpo>-associated <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>In addition, <z:mp ids='MP_0002169'>wild-type</z:mp> and p53 null human cell models were used to assess <z:chebi fb="0" ids="53388">PHB</z:chebi> interaction with STAT3 and p53 </plain></SENT>
<SENT sid="5" pm="."><plain><z:mp ids='MP_0002169'>Wild-type</z:mp> mice exhibited decreased mucosal <z:chebi fb="0" ids="53388">PHB</z:chebi> protein expression during <z:hpo ids='HP_0002583'>colitis</z:hpo>-associated <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Tg mice exhibited decreased susceptibility in a manner associated with <z:mp ids='MP_0006042'>increased apoptosis</z:mp>, p53, Bax, and Bad expression plus decreased Bcl-xL and Bcl-2 expression </plain></SENT>
<SENT sid="7" pm="."><plain><z:chebi fb="0" ids="53388">PHB</z:chebi> overexpression in <z:mp ids='MP_0002169'>wild-type</z:mp> but not p53 null human cells increased expression of Bax, Bad, and caspase-3 cleavage </plain></SENT>
<SENT sid="8" pm="."><plain>In <z:mp ids='MP_0002169'>wild-type</z:mp> p53 cells, <z:chebi fb="0" ids="53388">PHB</z:chebi> overexpression decreased basal and interleukin-6-induced STAT3 activation and expression of the STAT3 responsive genes Bcl-xL and Bcl-2 </plain></SENT>
<SENT sid="9" pm="."><plain><z:chebi fb="0" ids="53388">PHB</z:chebi> coimmunoprecipitated with phospho-STAT3 in addition to p53 in cultured cell lysates and colon mucosa </plain></SENT>
<SENT sid="10" pm="."><plain>This is the first study to show interaction between <z:chebi fb="0" ids="53388">PHB</z:chebi> and STAT3 in vivo </plain></SENT>
<SENT sid="11" pm="."><plain>In summary, our findings suggest that <z:chebi fb="0" ids="53388">PHB</z:chebi> protects against <z:hpo ids='HP_0002583'>colitis</z:hpo>-associated <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> by modulating p53- and STAT3-mediated <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="12" pm="."><plain>Modulation of <z:chebi fb="0" ids="53388">PHB</z:chebi> expression in intestinal epithelial cells may offer a potential therapeutic approach to prevent <z:hpo ids='HP_0002583'>colitis</z:hpo>-associated <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> </plain></SENT>
</text></document>